HS Code:
3,5-Difluoroaniline (CAS No. 372-39-4) is an organic chemical compound classified under HS Code 2921.42.65, which pertains to halogenated derivatives of aniline. It is primarily used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals. This compound is critical in industries requiring fluorinated aromatic amines for the development of active ingredients in drugs and pesticides. Its trade is influenced by the demand for high-purity chemical intermediates and stringent regulatory standards in chemical manufacturing.
Total Trade Volume
Approximately 1,200 metric tons
Data from 2022
Source
United Nations Comtrade Database and industry reports
500 metric tons
41.7% of total trade of total trade
Increasing
300 metric tons
25.0% of total trade of total trade
Increasing
150 metric tons
12.5% of total trade of total trade
Stable
100 metric tons
8.3% of total trade of total trade
Stable
80 metric tons
6.7% of total trade of total trade
Decreasing
Average Rate
5.5% ad valorem
Highest Rate
10% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-Japan EPA)
Rising demand in pharmaceutical sector
Increased production and trade volume due to the growing need for fluorinated intermediates in drug synthesis
2021-2022
Stricter environmental regulations
Higher compliance costs for manufacturers, potentially reducing supply from non-compliant regions
2020-2022
Shift towards sustainable chemical processes
Development of greener synthesis methods for 3,5-Difluoroaniline, influencing production costs and trade dynamics
2022
The European Union updated REACH regulations, imposing stricter guidelines on the import and use of fluorinated compounds like 3,5-Difluoroaniline, requiring detailed documentation and safety assessments.
March 2023
Potential delays in imports to EU markets and increased costs for exporters to meet compliance standards
Major chemical manufacturers in China announced plans to expand production facilities for fluorinated anilines to meet growing global demand, particularly from the pharmaceutical sector.
July 2022
Likely to increase export volumes from China, potentially lowering global prices due to economies of scale
The United States revised tariffs on certain chemical intermediates, including those under HS 2921.42, as part of trade negotiations, reducing rates for select trading partners.
January 2023
Expected to boost imports from countries with favorable trade agreements, reshaping supply chains